News search

E.g., 04/10/2024
E.g., 04/10/2024
Figure
Research
13 Sep 2024

RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors

Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
Research
16 Apr 2024

The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity

Carla Rothlin
About the CNIC
19 Dec 2023

Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School

En primer plano: Emilio Camafeita, Rui Benedito y Macarena Fernández; detrás, de izda. a dcha., Ana Dopazo, Jesús Vázquez, Alberto Benguria, Mariya Lytvyn, Severin Muhleder, Sofía Sánchez, Lourdes García.
Research
29 May 2023

The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer

Una cámara térmica muestra el efecto de la IL-12 sobre la grasa parda en ratón.
Research
9 Jun 2022

A study published in Hepatology demonstrates that the activation of thermogenesis in the livers of obese mice contributes to weight loss and improves diabetes symptoms

Imagen
About the CNIC
29 Jun 2021

 Over one million European cancer patients suffer from side effects to chemotherapy

Dra. Sabio
About the CNIC
17 Jun 2021

The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases.

Borja Ibáñez
About the CNIC
10 Jun 2021

The €35,000 awarded by the foundation in each category is for research that deepens knowledge of the relationship between nutrition, food and health

About the CNIC
9 Jun 2021

The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide


David Sancho, Carlos del Fresno, Elena Hernández-García, Manuel José Gómez, Francisco Javier Cueto, Salvador Iborra y Paola Brandi.
Research
14 May 2021

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have designed a new strategy to potentiate immunotherapy, the treatment that has revolutionized cancer management